| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Sophia Genetics SA's insiders have reduced their positions by a net 108,566 shares worth roughly $668K. In the past 30 days, 0 insiders bought and 1 sold.
On the other side, 1 insider reduced a position over the period. SOPH sits in the Health Information Services industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 3.49M | $28.92M | - | |
| Pres | 681.7K | $5.64M | - | |
| Other | 607.9K | $5.03M | -20,000 | |
| Other | 346.4K | $2.87M | - | |
| Other | 228.4K | $1.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Camblong Jurgi | Chief Executive Officer | Sell | 16,631 | $4.73 | $78,667.85 | -0.1% | +16.5% | - | |
| Apr 13, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 8,120 | $4.73 | $38,374.02 | -0.4% | +16.5% | - | |
| Apr 13, 2026 | Menu Philippe | Chief Medical Officer | Sell | 8,125 | $4.73 | $38,403.68 | -1.0% | +16.5% | - | |
| Apr 13, 2026 | Muken Ross | President | Sell | 8,129 | $4.73 | $38,444.89 | -0.6% | +16.5% | - | |
| Apr 10, 2026 | Van Well Daan | Chief Legal Officer | Sell | 2,400 | $4.67 | $11,201.28 | -0.7% | +23.8% | - | |
| Mar 31, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 3 | $4.71 | $14.13 | - | +16.2% | - |